News | December 02, 2013

Embolization Procedure Aids in Weight Loss

embolization devices rsna 2013 interventional

December 2, 2013 – A new study reports that individuals who underwent embolization of the left gastric artery for gastrointestinal bleeding experienced a 7.9 percent decrease in body weight three months after the procedure. Results of the study, which offer a potential new avenue for obesity research, will be presented next week at the annual meeting of the Radiological Society of North America (RSNA).

Transarterial embolization is a common interventional procedure used to treat a variety of medical conditions. In the image-guided procedure, an embolic, or obstructive, agent is inserted through a catheter and placed inside an artery to prevent blood flow in an artery or to a specific area of the body. Types of embolic agents include beads, coils and gel foam.

In the retrospective study conducted at Massachusetts General Hospital in Boston, researchers reviewed the records of patients who underwent transarterial embolization for upper gastrointestinal (GI) bleeding. The study group included 14 patients who underwent embolization of the left gastric artery, which supplies blood to the part of the stomach where the hormone ghrelin is predominantly produced.

"Ghrelin is the only hormone known to stimulate the appetite, so it is an intriguing potential target for combating obesity," said senior researcher Rahmi Oklu, M.D., Ph.D., assistant professor of radiology at Harvard Medical School. "Animal studies have shown that when this artery is blocked, blood levels of ghrelin decrease and weight loss occurs."

The study also included a review of the records of 18 age-matched control patients who were treated for upper GI bleeding with transarterial embolization of a different upper gastrointestinal artery. The study group included eight men and six women with a median age of 66.1 years; the control group included eight men and 10 women with a median age of 63.5 years.

The researchers found that patients who underwent left gastric artery embolization lost an average of 7.9 percent of their body weight within three months of the procedure. Weight loss within the control group was 1.2 percent during the same time frame.

"Embolizing the left gastric artery may be a potential bariatric treatment for weight loss and an alternative to other invasive procedures," Oklu said. "This is an important data point in the development of a new clinical tool for the treatment of obesity."

Oklu pointed out that left gastric artery embolization performed by an interventional radiologist is low risk when compared to more invasive weight loss interventions, such as gastric bypass and laparoscopic approaches.

"The effect of left gastric artery embolization will need to be studied in larger populations and eventually in prospective trials," he added.

The Centers for Disease Control and Prevention report that 69.2 percent of U.S. adults over the age of 20 are overweight, and 35.9 percent of adults over age 20 are obese.

Co-authors are Andrew J. Gunn, M.D. (lead author), and Elizabeth J. Hamilton, B.S.

AT A GLANCE

  • Individuals who underwent embolization of the left gastric artery for gastrointestinal bleeding experienced a 7.9 percent decrease in body weight three months after the procedure.
  • The left gastric artery supplies blood to the part of the stomach where the appetite-stimulating hormone ghrelin is predominantly produced.
  • Left gastric artery embolization is low risk when compared to more invasive weight loss interventions, such as gastric bypass and laparoscopic approaches.

 

For more information: RSNA.org

Related Content

Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Imaging | August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
Virtual Phantoms Inc. Releases VirtualDose-IR
Technology | Radiation Dose Management | August 07, 2017
Virtual Phantoms Inc. announced the release of VirtualDoseIR, a tool for assessing organ dose from interventional...
Moffitt Cancer Center Enhances Patient Care with Toshiba Medical's Infinix-i 4-D
News | Interventional Radiology | August 03, 2017
Cancer patients at Moffitt Cancer Center in Tampa, Fla., now have access to advanced diagnostic imaging for fast and...
Siemens Healthineers Announces First U.S. Install of Artis Pheno Angiography System
News | Angiography | July 05, 2017
July 5, 2017 — Michigan Medicine recently became the first healthcare institution in the United States to install the
Royal College of Radiologists Publishes New Guidance on Interventional Oncology
News | Interventional Radiology | May 25, 2017
May 25, 2017 —The Royal College of Radiologists (RCR) has published a new edition of its guidance on the application
Society of Interventional Radiology Backs Reallocations Bill for Graduate Medical Education
News | Interventional Radiology | May 24, 2017
Fourteen members of the Society of Interventional Radiology (SIR) took to Capitol Hill recently to express the society’...
Image Diagnostics Unveils Uni Diagnost UD1 at American Urology Association Meeting
Technology | Interventional Radiology | May 24, 2017
Image Diagnostics Inc. (IDI) recently unveiled the Uni Diagnost, the first integrated multipurpose imaging table, light...
Adept Medical Launches IR Platform, interventional radiology
Technology | Interventional Radiology | May 16, 2017
May 16, 2017 — Adept Medical announced the launch of the IR Platform, designed as an over-patient work surface for va
New Hampshire Hospital Expands Vascular Care with Toshiba Medical's Infinix-i Sky +
News | Angiography | April 27, 2017
Wentworth-Douglass Hospital in Dover, N.H., installed Toshiba Medical’s Infinix-i Sky + angiography system in its...
Louisiana Medical Center Installs First U.S. Toshiba Medical Infinix-i Sky +
News | Angiography | April 18, 2017
Patients at Terrebonne General Medical Center (TGMC) in Houma, La., now have access to safe, high-quality...
Overlay Init